IMARC Group’s latest report, titled “Preventive Healthcare Technologies and Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global preventive healthcare technologies and services market is expected to exhibit a CAGR of 13.2% during 2023-2028.
Preventive healthcare technologies and services include various necessary measures undertaken by healthcare providers to address medical concerns related to illnesses and their treatments. They comprise counteractive actions to ailments caused by a vaccination or disease diagnosis and help to address issues before an emergency room visit is required while detecting the progression of the disease. They use various devices and technologies to measure daily health parameters, such as blood oxygen saturation, heart rate, blood pressure, and sleep patterns, for early detection and screening, prophylaxis, and chronic disease management. Some of the common ailments that require extensive preventive healthcare technologies and services include diabetes, perpetual respiratory disorders, cardiovascular problems, and certain contagious illnesses.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/preventive-healthcare-technologies-services-market/requestsample
Competitive Landscape with Key Players:
The competitive landscape of the industry has also been examined along with the profiles of the key players being
- Abbott Laboratories
- GlaxoSmithKline PLC
- McKesson Corporation
- Medtronic PLC
- Merck & Co. Inc
- Myriad Genetics
- Omron Healthcare Inc
- Pfizer Inc
- Quest Diagnostics
- Sanofi S.A
Preventive Healthcare Technologies and Services Market Trends:
The escalating prevalence of chronic diseases among the masses majorly drives the global market. This can be attributed to the rising occurrences of lifestyle-associated and contagious diseases among individuals. Along with this, the accelerating geriatric population is increasing the demand for preventive healthcare technologies and services as they are more prone to ailments, thereby catalyzing the market. Apart from this, the rapid outbreak of coronavirus disease (COVID-19) has impelled the demand for screening among infected individuals has further impacted the demand on the global level. Moreover, the widespread adoption of cloud-based technologies to enhance clinical quality, preventive healthcare delivery, and operational efficiency are creating a positive market outlook. Some other factors driving the market include extensive research and development (R&D) activities and the continuous upgradation of healthcare infrastructure.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=6209&flag=C
Key Market Segmentation:
Breakup by Type:
- Early Detection and Screening
- Vaccines
- Chronic Diseases Management
- Advanced Technologies to Reduce Errors
Breakup by Application:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Browse More Research Reports:
- Healthcare Predictive Analytics Market Demand and Growth
- Hemodynamic Monitoring Market Demand and Growth
- Hepatitis Diagnostic Tests Market Demand and Growth
- Hereditary Angioedema Therapeutic Market Demand and Growth
- Hydroponics Market Demand and Growth
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com